Smits A - Search Results

1

A Population Model of Time-Dependent Changes in Serum Creatinine in (Near)term Neonates with Hypoxic-Ischemic Encephalopathy During and After Therapeutic Hypothermia.

Krzyzanski W, Wintermark P, Annaert P, Groenendaal F, Şahin S, Öncel MY, Armangil D, Koc E, Battin MR, Gunn AJ, Frymoyer A, Chock VY, Keles E, Mekahli D, van den Anker J, Smits A, Allegaert K. Krzyzanski W, et al. Among authors: smits a. AAPS J. 2023 Dec 5;26(1):4. doi: 10.1208/s12248-023-00851-0. AAPS J. 2023. PMID: 38051395 Free PMC article.

2

Perinatal pharmacology: applications for neonatal neurology.

Smits A, Allegaert K. Smits A, et al. Eur J Paediatr Neurol. 2011 Nov;15(6):478-86. doi: 10.1016/j.ejpn.2011.04.007. Epub 2011 May 14. Eur J Paediatr Neurol. 2011. PMID: 21576027 Review.

3

Quantification of amikacin in bronchial epithelial lining fluid in neonates.

Tayman C, El-Attug MN, Adams E, Van Schepdael A, Debeer A, Allegaert K, Smits A. Tayman C, et al. Among authors: smits a. Antimicrob Agents Chemother. 2011 Sep;55(9):3990-3. doi: 10.1128/AAC.00277-11. Epub 2011 Jun 27. Antimicrob Agents Chemother. 2011. PMID: 21709076 Free PMC article.

4

Pharmacokinetics of Drugs in Neonates: Pattern Recognition Beyond Compound Specific Observations.

Smits A, Kulo A, de Hoon JN, Allegaert K. Smits A, et al. Curr Pharm Des. 2012 Feb 27. Online ahead of print. Curr Pharm Des. 2012. PMID: 22385063

5

Physiologically based pharmacokinetic modeling in pediatric drug development: a clinician's request for a more integrated approach.

Allegaert K, Smits A, van den Anker JN. Allegaert K, et al. Among authors: smits a. J Biomed Biotechnol. 2012;2012:103763. doi: 10.1155/2012/103763. Epub 2012 Mar 5. J Biomed Biotechnol. 2012. PMID: 22500073 Free PMC article. No abstract available.

6

Drug disposition and clinical practice in neonates: cross talk between developmental physiology and pharmacology.

Smits A, Annaert P, Allegaert K. Smits A, et al. Int J Pharm. 2013 Aug 16;452(1-2):8-13. doi: 10.1016/j.ijpharm.2012.03.035. Epub 2012 Apr 5. Int J Pharm. 2013. PMID: 22504091 Review.

7

Pharmacokinetics of drugs in neonates: pattern recognition beyond compound specific observations.

Smits A, Kulo A, de Hoon JN, Allegaert K. Smits A, et al. Curr Pharm Des. 2012;18(21):3119-46. doi: 10.2174/1381612811209023119. Curr Pharm Des. 2012. PMID: 22564304 Review.

8

The impact of Caesarean delivery on paracetamol and ketorolac pharmacokinetics: a paired analysis.

Kulo A, van Calsteren K, Verbesselt R, Smits A, Devlieger R, de Hoon J, Allegaert K. Kulo A, et al. Among authors: smits a. J Biomed Biotechnol. 2012;2012:437639. doi: 10.1155/2012/437639. Epub 2012 May 20. J Biomed Biotechnol. 2012. PMID: 22675252 Free PMC article.

9

Is indirect hyperbilirubinemia a useful biomarker of reduced propofol clearance in neonates?

Smits A, De Cock RF, Cossey V, Knibbe CA, Allegaert K. Smits A, et al. Biomark Med. 2012 Jun;6(3):283-9. doi: 10.2217/bmm.12.25. Biomark Med. 2012. PMID: 22731901

10

Cefazolin plasma protein binding and its covariates in neonates.

Smits A, Kulo A, Verbesselt R, Naulaers G, de Hoon J, Vermeersch P, Allegaert K. Smits A, et al. Eur J Clin Microbiol Infect Dis. 2012 Dec;31(12):3359-65. doi: 10.1007/s10096-012-1703-x. Epub 2012 Jul 26. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22833246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

777 results

Search Page

Filters